Leo is not listening to any BUYOUT offers at this stage in clinical Trials..

Buyout will be in 2018 when there are 5 registration studies....Leo will be 60 and 10,000,000 of his stock options are set to expire in 2019....

50 bucks a share will be a slap in the face in 2018....

The $$$$ figure is correct but the Patient figures are not...S/B Millions not billions of patients...

UP Cohort B results next week....


ALL ABOARD!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

LOL!!! and not laughing out loud...

B-UP final results
P Interim results
B-OM Interim results

April is lining up to be the perfect storm.
All shorts drowned at SEAceutix!!


TIC TOC KABOOOOOOOOOOOOOOOOOM!!!

Enjoy March shorties cause it's your Last month here if that long:)

Cohort C will be done the 1st week of April.

Results not to long after!

TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!!

and the shorts KNEW it!!!!!!

6 weeks of treatment for UP Cohort b
is done. Results at anytime:)

TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!

and the shorts know it

Karin if they are NOT using the entire 189 patients for the 6 week data then you are correct. Interim analysis could be at anytime!
Maybe after market close:)

KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!

SPLAT GO THE SHORTS!

Prurisol is a 2b. Isn't it?

OUTSTANDING UP Cohort B results next week.....

BP is LOVING Cellceutix more and more each trial...

Yup you are late.....That would be HUGE!!!

you mean as jav0033

shouldn't take long at all to see if Kevetrin is working.....


TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!


and the shorts know it!!

K for Ovarian status is now RECRUITING!
https://clinicaltrials.gov/ct2/show/NCT03042702?term=cellceutix&rank=2



TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!

and the shorts know it!!!

If P proves to be as good as or even close to Biologics (Enbrel,humira..etc)

The share price will hit the moon before any deal.

Not even close on P or B.

What else ya got Giovanni?

Siliq is a JOKE!!!
Who's gonna buy this crap?


"Because of the observed risk of suicidal ideation and behavior, the labeling for Siliq includes a Boxed Warning and the drug is only available through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Siliq REMS Program," as stated in the FDA’s press release.

The statement goes on to list requirements of the program, stating,

"Prescribers must be certified with the program and counsel patients about this risk. Patients with new or worsening symptoms of depression or suicidality should be referred to a mental health professional, as appropriate."
"Patients must sign a Patient-Prescriber Agreement Form and be made aware of the need to seek medical attention should they experience new or worsening suicidal thoughts or behavior, feelings of depression, anxiety or other mood changes."
"Pharmacies must be certified with the program and must only dispense to patients who are authorized to receive Siliq."

Siliq won't even sell..

The most common side effects included joint pain, headache, fatigue, diarrhea, throat pain, nausea, muscle pain and injection-site reactions. More-serious potential side effects are suicidal thoughts and behavior, especially among people with a history of suicidal behavior or depression, the FDA said.

and you need to INJECT it!!!!

TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!

and the shorts know it!!!!!

That drug has a black box warning for SUICIDES!!!
4 people killed themselves during treatment.
That drug should not have been approved at all.

I agree.

P
B Up
K Ovarian

These 3 will be HUGE deals in 2017.


TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!

and the shorts know it!!!!!!

2/28 is by June.

Bertolino headed the last PR...Leo just chimed in....


TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!!!!

AND THE SHORTS KNOW IT!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

I don't buy the theory of some on here who think B-ABSsSI up and om are a package deal. Actually I haven't heard that mentioned in a few months so maybe they changed their minds on that.

IMO Leo will make a deal for each indication separately with upfront money/milestone payments and royalties. That goes for B K and P.

That's how you build a regeneron...or better:)

Expect CTIX to be between $3 and $4 by or before the end of February 2017!!!

Good luck and GOD bless,
Runninggirl2016

So will Open Label for K-O...

B UP a winner for sure:

http://www.cellceutix.com/new-blog/2017/2/2/endoscopic-remission-in-the-treatment-of-ulcerative-colitis

not trying to run 4 trials they ARE running 4 trials with $3.9M to spare!

NICE WORK LEO!!!!


TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!!

UP trial is a winner

P trial is a winner

OM trial is a winner

Interim readout in 2q tells me it will contain ALL 189 patients.

Karin Patient enrollment is actually slower in 2b.
it took 3.5 months to enroll 115 patients in 9 sites even after they started off with only 2-3 sites...

2B is at 3.25 months for 189 patients with 25 sites and starting off with 13.

I assume it's easier to find mild patients since mild/mod make up 80% of Psorisis patients ww.

Karin so you are saying the interim results will not be for all 189 patients?

Joey no way that's happening.
You have been brainwashed...

Rabbits tend to be farsighted, which means they can see long distances really well. However, their vision for items nearby isn't always so great.

12 days left in February
then the heat gets turned up!!!


TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!

Cabel so you are saying with 2-3 BILLION in the bank from Prurisol Cellceutix MC would be 3-4 billion? Really?

“I think it is pretty easy to see why we are thrilled at our prospects with four different mid-stage trials ongoing,” said Arthur P. Bertolino, MD, PhD, MBA, President and Chief Medical Officer at Cellceutix. “Each study has a valuable component in demonstrating the robustness and potential of our pipeline and I greatly look forward to what I suspect will be a 2017 with a steady flow of information across all four trials.”


P 2b DONE this year
OM Done this year
UP Done this year
K-O Done this year

At LEAST 2 HUGE partnerships. 5-10 Billion MC.

You do the math.

Transform Cellceutix Overnight!

Not something shorts wanted to hear...